Results 11 to 20 of about 895 (134)

Bevacizumab versus ziv-aflibercept in branch retinal vein occlusion [PDF]

Indian Journal of Ophthalmology, 2019
Purpose: To compare the effectiveness of treatment with intravitreal bevacizumab (IVB) and ziv-aflibercept (IVZ) in patients with macular edema (ME) post-branch retinal vein occlusion (BRVO).
Imoro Z Braimah, Sumit Randhir Singh, Bhushan Uplanchiwar, Ahmad M Mansour, Jay Chhablani   +4 more
doaj   +4 more sources

Intravitreal ziv-aflibercept for macular edema following retinal vein occlusion [PDF]

Clinical Ophthalmology, 2016
Remya Paulose,1 Jay Chhablani,1 Chintan J Dedhia,1 Michael W Stewart,2 Ahmad M Mansour3,4 1Smt. Kanuri Santhamma Centre for Vitreoretinal Diseases, LV Prasad Eye Institute, Hyderabad, India; 2Department of Ophthalmology, Mayo Clinic, Jacksonville, FL ...
Paulose R, Chhablani J, Dedhia CJ, Stewart MW, Mansour AM   +4 more
doaj   +6 more sources

Ziv-aflibercept in Diabetic Macular Edema: Relation of Subfoveal Choroidal Thickness with Visual and Anatomical Outcomes [PDF]

Journal of Ophthalmic & Vision Research, 2023
Purpose: To evaluate the effects of intravitreal ziv-aflibercept injections (IVZ) on subfoveal choroidal thickness (SCT) as well as on central macular thickness (CMT) and on best corrected visual acuity (BCVA) changes in eyes with center-involved ...
Siamak Moradian, Masoud Soheilian, Mahsan Asadi, Abdolreza Baghi, Hamid Safi, Seyed-Hossein Abtahi   +5 more
doaj   +2 more sources

Evaluation of aflibercept and ziv-aflibercept binding affinity to vascular endothelial growth factor, stability and sterility after compounding [PDF]

International Journal of Retina and Vitreous, 2018
Purpose To investigate the binding affinity, stability, and sterility of aflibercept and ziv-aflibercept to vascular endothelial growth factor (Holash et al. in Proc Natl Acad Sci USA 99(17):11393–11398, 2002.
Julia de Lima Farah, Ronaldo Sano, Ieda Maria Longo Maugéri, Daniela Teixeira, Mayari Eika Ishimura, Gabriela Martins, Lycia M. J. Mimica, Cely Barreto da Silva, Carsten H. Meyer, João Rafael de Oliveira Dias, Gabriel Costa de Andrade, Michel Eid Farah   +11 more
doaj   +2 more sources

A combination of suprachoroidal injection of triamcinolone using a custom-made needle and intravitreal Ziv-aflibercept every eight weeks to manage naïve/denovo central DME: a single-center retrospective case series [PDF]

International Journal of Retina and Vitreous
Background Previous studies have shown promising effects of combining intravitreal bevacizumab and suprachoroidal injection of triamcinolone acetonide in treating DME. However, further research is needed.
Ameen Marashi, Marwa Baba, Sedra Abu Ghedda, Mohammad Nour Kitaz, Aya Zazo   +4 more
doaj   +2 more sources

Comparison of antiangiogenic agents (ranibizumab, aflibercept, bevacizumab and ziv-aflibercept) in the therapeutic response to the exudative form of age-related macular degeneration according to the treat-and-extend protocol- true head-to-head study [PDF]

International Journal of Retina and Vitreous
Purpose To evaluate the structural and functional changes in eyes with neovascular age related macular degeneration (nAMD) in a real-world setting, using Treat and Extend protocol (T&E), comparing four antiangiogenic agents.
Tereza Kanadani, Neiffer Rabelo, Denise Takahashi, Lucas Magalhães, Michel Farah   +4 more
doaj   +2 more sources

Ziv-aflibercept and bevacizumab for exudative age-related macular degeneration: A retrospective comparison of clinical outcomes and cost at 1 year [PDF]

Taiwan Journal of Ophthalmology, 2020
PURPOSE: The purpose of this study was to compare intravitreal ziv-aflibercept (IVZ) monotherapy to intravitreal bevacizumab (IVB) monotherapy in patients with exudative age-related macular degeneration (eAMD).
Sumit Randhir Singh, Ravi Parikh, Yoichi Sakurada, Bhushan Uplanchiwar, Ahmad Mansour, Abhilash Goud, Yasha S Modi, Jay Chhablani   +7 more
doaj   +2 more sources

A phase Ib study of capecitabine and ziv-aflibercept followed by a phase II single-arm expansion cohort in chemotherapy refractory metastatic colorectal cancer [PDF]

BMC Cancer, 2019
Background Patients with chemotherapy refractory metastatic colorectal cancer (CRC) have a poor prognosis and limited therapeutic options. In this phase Ib/II clinical trial, we established the maximum tolerated dose (MTD) and recommended phase II dose ...
John H. Strickler, Christel N. Rushing, Donna Niedzwiecki, Abigail McLeod, Ivy Altomare, Hope E. Uronis, S. David Hsu, S. Yousuf Zafar, Michael A. Morse, David Z. Chang, James L. Wells, Kimberly L. Blackwell, P. Kelly Marcom, Christy Arrowood, Emily Bolch, Sherri Haley, Fatima A. Rangwala, Ace J. Hatch, Andrew B. Nixon, Herbert I. Hurwitz   +19 more
doaj   +2 more sources

Comparison of intravitreal ziv-aflibercept and bevacizumab monotherapy in treatment-naive polypoidal choroidal vasculopathy [PDF]

Indian Journal of Ophthalmology, 2019
Purpose: To report the visual and anatomical outcomes of intravitreal ziv-aflibercept (IVZ) and bevacizumab (BVZ) monotherapy in treatment-naive polypoidal choroidal vasculopathy (PCV).
Sumit Randhir Singh, Niroj Kumar Sahoo, Nallamasa Rohit Goud, Jay Chhablani   +3 more
doaj   +2 more sources

Photodynamic therapy in combination with intravitreal ziv-aflibercept and aflibercept injection in patients with chronic or repeatedly recurrent acute central serous chorioretinopathy: a single-center retrospective study [PDF]

Clinical Ophthalmology, 2018
Juliane Maria Doepfner,1 Stephan Michels,1,2 Nicole Graf,3 Matthias Dieter Becker,1 Florentina Joyce Freiberg1 1Department of Ophthalmology, Triemli City Hospital, Zurich, Switzerland; 2Faculty of Medicine, University of Zurich, Zurich, Switzerland ...
Doepfner JM, Michels S, Graf N, Becker MD, Freiberg FJ   +4 more
doaj   +2 more sources